Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
FDA approves transformational expansion of Ionis’ Tryngolza
Ionis has gained a transformational FDA expansion for Tryngolza to become the first treatment to reduce the risk of acute pancreatitis that accompanies severe hypertriglyceridemia.
Kevin Dunleavy
Jun 25, 2026 8:13am
FDA issues Form 483 to Dr. Reddy's plant in India
Jun 26, 2026 11:40am
EC begins antitrust probe into Sanofi's flu shot campaign
Jun 26, 2026 11:20am
Europe's CHMP reverses endorsement of Amgen's Tavneos
Jun 26, 2026 11:07am
Regulatory tracker: Keytruda-Padcev wins EU expansion
Jun 26, 2026 10:38am
Solid tumor CAR-T, Pfizer-Innovent, China deals—Fierce Pharma Asia
Jun 26, 2026 8:51am
More News
BeOne boosts support for Blood Cancer United with $5M commitment
Jun 26, 2026 3:57am
Fosun Pharma plots global push, fueled by Alzheimer’s deals
Jun 25, 2026 7:00pm
SCOTUS ruling blunts state-level claims against Bayer's Roundup
Jun 25, 2026 1:52pm
FDA finds fault with Pinnacle’s photodynamic therapy videos
Jun 25, 2026 10:12am
